Pietro Pozzi

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

Flavio Leoni, Andrea Zaliani, Giorgio Bertolini et al. · Proceedings of the National Academy of Sciences · 2002 · 509 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo

Flavio Leoni, Gianluca Fossati, Eli C. Lewis et al. · Molecular Medicine · 2005 · 333 citations · Full text

Medicine, Immunology, Pharmacology +17

Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1

Fabio Benigni, Giamila Fantuzzi, Silvano Sacco et al. · Blood · 1996 · 115 citations

Life Sciences, Endocrinology, Immunology +16

The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells

Josée Golay, Lucia Cuppini, F. Leoni et al. · Leukemia · 2007 · 106 citations

Life Sciences, Molecular Biology, Oncology +13

Specific Inhibition of Histone Deacetylase 8 Reduces Gene Expression and Production of Proinflammatory Cytokines in Vitro and in Vivo

Suzhao Li, Gianluca Fossati, Carlo Marchetti et al. · Journal of Biological Chemistry · 2014 · 62 citations · Full text

Life Sciences, Immunology, Molecular Biology +14